Interim results in clinical trials: do we need to keep all interim randomised clinical trial results confidential?
about
Sharing interim trial results by the Data Safety Monitoring Board with those responsible for the trial's conduct and progress: a narrative review.Commentary: data monitoring confidentiality and FDA transparency.RADVAN: a randomised phase 2 trial of WBRT plus vandetanib for melanoma brain metastases - results and lessons learnt.Accrual monitoring in cardiovascular trials.Threat of interim data leaks prompts call for international rules.Characteristics of Interim Publications of Randomized Clinical Trials and Comparison With Final Publications.
P2860
Interim results in clinical trials: do we need to keep all interim randomised clinical trial results confidential?
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Interim results in clinical tr ...... al trial results confidential?
@ast
Interim results in clinical tr ...... al trial results confidential?
@en
Interim results in clinical tr ...... al trial results confidential?
@nl
type
label
Interim results in clinical tr ...... al trial results confidential?
@ast
Interim results in clinical tr ...... al trial results confidential?
@en
Interim results in clinical tr ...... al trial results confidential?
@nl
prefLabel
Interim results in clinical tr ...... al trial results confidential?
@ast
Interim results in clinical tr ...... al trial results confidential?
@en
Interim results in clinical tr ...... al trial results confidential?
@nl
P2093
P1433
P1476
Interim results in clinical tr ...... al trial results confidential?
@en
P2093
M K B Parmar
M Nankivell
P Mulvenna
R E Langley
R J Stephens
P304
P356
10.1016/J.LUNGCAN.2014.05.012
P407
P50
P577
2014-05-22T00:00:00Z